Drug Induced Liver Injury Clinical Trial
Official title:
Identification of New Biomarkers of Drug Induced Liver Injury
The purpose of this study is to try to develop new blood tests that may help doctors identify if a drug is hurting a person's liver.
Our hypothesis is that there are liver-specific particles, called mRNA, that are identifiable in a person's blood sample during liver injury caused by some drugs. The purpose of this study is to try to develop new blood tests that may help doctors identify if a drug is hurting a person's liver, perhaps early in the process before significant injury or illness have occurred. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05738681 -
Efficacy of N-acetylcysteine to Prevent Anti-tuberculosis Drug-induced Liver Injury: A Randomized Controlled Trial
|
Phase 2/Phase 3 | |
| Recruiting |
NCT00360646 -
Drug-Induced Liver Injury (DILI) Network Retrospective
|
||
| Recruiting |
NCT05789797 -
Remaxol® in Patients With Drug-induced Liver Injuries During Cancer Chemotherapy
|
||
| Terminated |
NCT02686385 -
Efficacy of N-acetylcysteine With or Without Steroids in Drug Induced Liver Injury
|
N/A | |
| Recruiting |
NCT06446609 -
Drug-induced Liver Injury: Itching Study
|
||
| Active, not recruiting |
NCT04269486 -
A Multicenter Observational Study on Safety of the Herbal Medicines at Inpatient Setting
|
||
| Recruiting |
NCT06192589 -
Clinical Study to Evaluate Cannabidiol Liver Enzyme Elevations and Drug Interactions
|
Phase 1 | |
| Completed |
NCT00616018 -
Acetaminophen Adduct Formation in Non-Drinkers Taking Therapeutic Doses of Acetaminophen for Ten Consecutive Days
|
Phase 4 | |
| Withdrawn |
NCT01137591 -
Acetaminophen in Combination With N-Acetylcysteine (NAC) Versus Placebo in Treating Fever
|
N/A |